AU4348593A - Chromanderivatives as angiotensin ii antagonists - Google Patents

Chromanderivatives as angiotensin ii antagonists

Info

Publication number
AU4348593A
AU4348593A AU43485/93A AU4348593A AU4348593A AU 4348593 A AU4348593 A AU 4348593A AU 43485/93 A AU43485/93 A AU 43485/93A AU 4348593 A AU4348593 A AU 4348593A AU 4348593 A AU4348593 A AU 4348593A
Authority
AU
Australia
Prior art keywords
chromanderivatives
angiotensin
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43485/93A
Inventor
Andrew Peter Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213474A external-priority patent/GB9213474D0/en
Priority claimed from GB929216779A external-priority patent/GB9216779D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AU4348593A publication Critical patent/AU4348593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43485/93A 1992-06-25 1993-06-18 Chromanderivatives as angiotensin ii antagonists Abandoned AU4348593A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929213474A GB9213474D0 (en) 1992-06-25 1992-06-25 Nitrogen derivatives
GB9213474 1992-06-25
GB929216779A GB9216779D0 (en) 1992-08-07 1992-08-07 Heterocyclic compounds
GB9216779 1992-08-07
PCT/GB1993/001294 WO1994000450A1 (en) 1992-06-25 1993-06-18 Chromanderivatives as angiotensin ii antagonists

Publications (1)

Publication Number Publication Date
AU4348593A true AU4348593A (en) 1994-01-24

Family

ID=26301124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43485/93A Abandoned AU4348593A (en) 1992-06-25 1993-06-18 Chromanderivatives as angiotensin ii antagonists

Country Status (2)

Country Link
AU (1) AU4348593A (en)
WO (1) WO1994000450A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107922396B (en) * 2015-07-20 2022-08-05 建新公司 Colony stimulating factor-1 receptor (CSF-1R) inhibitors
EP4267573A1 (en) 2020-12-23 2023-11-01 Genzyme Corporation Deuterated colony stimulating factor-1 receptor (csf-1r) inhibitors
WO2023078252A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2075627A1 (en) * 1990-02-13 1991-08-14 William J. Greenlee Angiotensin ii antagonists incorporating a substituted benzyl element
US5187159A (en) * 1991-10-07 1993-02-16 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole

Also Published As

Publication number Publication date
WO1994000450A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
AU3998593A (en) Angiotensin II antagonists
AU3122793A (en) Substituted heterocycles as angiotensin ii antagonists
AU679712B2 (en) Endothelin antagonists
AU5342894A (en) Tachykinin antagonists
AU8374491A (en) Angiotensin II receptor antagonists
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU3665793A (en) Fibrinogen receptor antagonists
EP0574846A3 (en) Imidazopyridines as angiotensin ii antagonistes
AU4540793A (en) Benzimidazole compounds
AU8268191A (en) Bradykinin antagonists
AU3276293A (en) Angiotensin II receptor antagonists
GB9317760D0 (en) Angiotensin ii antagonist
AU5327294A (en) Pyrroloquinoline bradykinin antagonist
IL107400A0 (en) Bradykinin antagonists
AU4540593A (en) Benzimidazole compounds
AU4488393A (en) Antacid
AU6856796A (en) Des-arg9-bk antagonists
GB9317758D0 (en) Angiotensin ii antagonist
AU4931693A (en) Ibuprofen-h2 antagonist combinations
AU6090594A (en) Angiotensin ii inhibitors
AU685767B2 (en) Substituted benzazepinones
AU5455194A (en) Substituted phthalazinones as nerotensin antagonists
AU667580B2 (en) Line-handling block
AU3384593A (en) N-aryl-nitrogen heterocycles
AU3679693A (en) Benzimidazoles